Ashley Hill
Acute Care · Indianapolis, INNPI 1801547153
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $5,075 of the $6,565 with a category attached, or 77.3%. Inari Medical, Inc. accounts for 79.5% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2023 at $5,284 and has fallen 90.5% since, to $501 in 2025. Among acute care clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 53 payments — averaging $123.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$5K
- Trisalus Life Sciences, Inc.$492
- Boston Scientific$242
- Sirtex Medical Inc$178
- Stryker$147
- Bard Peripheral Vascular, Inc.$86
- plus $199 from 6 others
What the payments were for
- Speaking & faculty fees$5,07577%
- Food & beverage$1,49023%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inari Medical, Inc. | 8 | $5,220 |
| Trisalus Life Sciences, Inc. | 27 | $492 |
| Boston Scientific | 6 | $242 |
| Sirtex Medical Inc | 2 | $178 |
| Stryker | 2 | $147 |
| Bard Peripheral Vascular, Inc. | 1 | $86 |
| Philips North America LLC | 1 | $74 |
| Terumo Medical Corporation | 2 | $45 |
| Imperative Care, Inc | 1 | $29 |
| Teleflex LLC | 1 | $20 |
| Avanos Medical | 1 | $17 |
| Siemens Medical Solutions USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,565 in reported general payments places this provider in the 95th percentile of 240 acute care providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Methylprednisolone | 29 | $204 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $176 |
| Ondansetron OdtOndansetron | 16 | $142 |
| ClopidogrelClopidogrel Bisulfate | 15 | $74 |
| Clindamycin Hcl | 12 | $49 |
Paid to pharmacies, not to this prescriber.
Other acute care in Indianapolis
- Lauren ArmingtonIndianapolis$7K
- Rebecca DavidhizarIndianapolis$3K
- Jennifer JimenezIndianapolis$3K
- Jennifer DimitroffIndianapolis$3K
- Lisa SimsIndianapolis$3K
- Kylie BeutlerIndianapolis$2K
- Alexis SmithIndianapolis$2K
- Katelyn PorterIndianapolis$2K
- Rebecca CobbIndianapolis$2K
- Jennifer BrowerIndianapolis$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.